Basics
Fluspirilene is a long-acting antipsychotic used in chronic schizophrenia. It is formulated as a sustained-release drug and administered parenterally.
Effect
Pharmacodynamics
Fluspirilene does not differ significantly in its action from other antipsychotics such as fluphenazine or perphenazine. Like the other representatives of this group, fluspirilene blocks dopamine receptors and thus achieves its sedative, drive-reducing and, above all, antipsychotic effect.
Toxicity
Side effects
- Fatigue
- Sleep disorders
- hypertension
- Cardiac arrhythmias
- tachycardia
- Dry mouth
- Nausea,
- vomiting
- Diarrhea
Contraindications and precautions
The drug must not be used in diseases caused by dopamine deficiency. This includes mainly Parkinson's disease.
The effect of sleeping pills and alcohol may be enhanced by concomitant use of fluspirilene.
| ATC Code | N05AG01 |
| Formula | C29H31F2N3O |
| Molar Mass (g·mol−1) | 475.584 |
| Physical State | solid |
| Melting Point (°C) | 187.5-190 |
| PKS Value | 8.66 |
| CAS Number | 1841-19-6 |
| PUB Number | 3396 |
| Drugbank ID | DB04842 |
Sources
All information used for the content comes from verified sources (recognised institutions, experts, studies by renowned universities). We attach great importance to the qualification of the authors and the scientific background of the information. Thus, we ensure that our research is based on scientific findings.
The content of this page is an automated and high-quality translation from DeepL. You can find the original content in German here.
Ad